Business Description
Abeona Therapeutics Inc
NAICS : 325413
SIC : 2834
Description
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its lead clinical programs consist of EB-101, autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa; ABO-102, adeno-associated virus-based gene therapy for Sanfilippo syndrome type A, and ABO-101, an AAV-based gene therapy for Sanfilippo syndrome type B.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.19 | |||||
| Equity-to-Asset | 0.4 | |||||
| Debt-to-Equity | 0.54 | |||||
| Debt-to-EBITDA | -0.1 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -30.56 | |||||
| Beneish M-Score | -1.25 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -21.5 | |||||
| 3-Year EBITDA Growth Rate | 11.9 | |||||
| 3-Year EPS without NRI Growth Rate | 10.3 | |||||
| 3-Year FCF Growth Rate | 16.8 | |||||
| 3-Year Book Growth Rate | -50 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 67.49 | |||||
| 9-Day RSI | 58.71 | |||||
| 14-Day RSI | 55.32 | |||||
| 6-1 Month Momentum % | -25.74 | |||||
| 12-1 Month Momentum % | -68.97 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.02 | |||||
| Quick Ratio | 2.02 | |||||
| Cash Ratio | 1.44 | |||||
| Days Sales Outstanding | 167.97 | |||||
| Days Payable | 2351.23 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -45.3 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 91.95 | |||||
| Operating Margin % | -1091.97 | |||||
| Net Margin % | -1961.64 | |||||
| ROE % | -215.22 | |||||
| ROA % | -126.39 | |||||
| ROIC % | -178.13 | |||||
| ROC (Joel Greenblatt) % | -519.03 | |||||
| ROCE % | -165.36 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 0.12 | |||||
| PS Ratio | 2.86 | |||||
| PB Ratio | 1.35 | |||||
| Price-to-Tangible-Book | 1.35 | |||||
| EV-to-EBIT | -0.43 | |||||
| EV-to-EBITDA | -0.46 | |||||
| EV-to-Revenue | 8.44 | |||||
| EV-to-Forward-Revenue | 0.29 | |||||
| EV-to-FCF | -0.58 | |||||
| Price-to-Net-Current-Asset-Value | 9.68 | |||||
| Earnings Yield (Greenblatt) % | -232.56 |
How Abeona Therapeutics Inc (ABEO) Makes Its Money
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ABEO
Peter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 4.346 | ||
| EPS (TTM) ($) | -18.31 | ||
| Beta | 1.36 | ||
| Volatility % | 85.87 | ||
| 14-Day RSI | 55.32 | ||
| 14-Day ATR ($) | 0.23047 | ||
| 20-Day SMA ($) | 2.5535 | ||
| 12-1 Month Momentum % | -68.97 | ||
| 52-Week Range ($) | 2.19 - 9.355 | ||
| Shares Outstanding (Mil) | 17.18 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Abeona Therapeutics Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Abeona Therapeutics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Abeona Therapeutics Inc Frequently Asked Questions
What is Abeona Therapeutics Inc(ABEO)'s stock price today?
The current price of ABEO is $2.71. The 52 week high of ABEO is $9.36 and 52 week low is $2.19.
When is next earnings date of Abeona Therapeutics Inc(ABEO)?
The next earnings date of Abeona Therapeutics Inc(ABEO) is 2023-03-31 Est..
Does Abeona Therapeutics Inc(ABEO) pay dividends? If so, how much?
Abeona Therapeutics Inc(ABEO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
